XBiotech Inc (XBIT)
8.61
-0.72
(-7.72%)
USD |
NASDAQ |
May 09, 16:00
8.61
0.00 (0.00%)
After-Hours: 20:00
XBiotech Cash from Operations (TTM): -18.72M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -18.72M |
September 30, 2023 | -18.46M |
June 30, 2023 | -18.12M |
March 31, 2023 | -14.51M |
December 31, 2022 | -14.82M |
September 30, 2022 | -13.42M |
June 30, 2022 | -15.67M |
March 31, 2022 | 62.51M |
December 31, 2021 | 69.44M |
September 30, 2021 | 70.81M |
June 30, 2021 | 81.70M |
March 31, 2021 | -2.667M |
December 31, 2020 | -65.15M |
September 30, 2020 | -68.50M |
June 30, 2020 | -80.97M |
March 31, 2020 | -74.27M |
December 31, 2019 | -18.27M |
September 30, 2019 | -19.64M |
June 30, 2019 | -18.65M |
Date | Value |
---|---|
March 31, 2019 | -17.69M |
December 31, 2018 | -16.54M |
September 30, 2018 | -18.23M |
June 30, 2018 | -20.70M |
March 31, 2018 | -25.27M |
December 31, 2017 | -33.65M |
September 30, 2017 | -39.64M |
June 30, 2017 | -48.19M |
March 31, 2017 | -47.98M |
December 31, 2016 | -46.02M |
September 30, 2016 | -43.91M |
June 30, 2016 | -36.11M |
March 31, 2016 | -36.72M |
December 31, 2015 | -33.31M |
September 30, 2015 | -26.06M |
June 30, 2015 | -22.07M |
March 31, 2015 | -15.89M |
December 31, 2014 | -11.70M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-80.97M
Minimum
Jun 2020
81.70M
Maximum
Jun 2021
-9.335M
Average
-18.12M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |